161 related articles for article (PubMed ID: 23774843)
1. Preventive effect of pidotimod on reactivated toxoplasmosis in mice.
Huo XX; Wang L; Chen ZW; Chen H; Xu XC; Zhang AM; Song XR; Luo QL; Xu YH; Fu Y; Wang H; Du J; Cai YH; Lun ZR; Lu FL; Wang Y; Shen JL
Parasitol Res; 2013 Aug; 112(8):3041-51. PubMed ID: 23774843
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
Zhao Y; Huang B; Huang S; Zheng H; Li YQ; Lun ZR; Shen J; Wang Y; Kasper LH; Lu F
Parasitol Res; 2013 Sep; 112(9):3151-60. PubMed ID: 23783399
[TBL] [Abstract][Full Text] [Related]
3. [Pidotimod inhibits activation of latent Toxoplasma gondii infection induced by dexamethasone in mice].
Wang WW; Huo XX; Kong LT; Zhang Q; Chen H; Li M; Shen JL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Oct; 31(5):385-9. PubMed ID: 24818397
[TBL] [Abstract][Full Text] [Related]
4. Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression.
Du XF; Jiang CZ; Wu CF; Won EK; Choung SY
Arch Pharm Res; 2008 Sep; 31(9):1153-9. PubMed ID: 18806958
[TBL] [Abstract][Full Text] [Related]
5. Pidotimod and Immunological Activation in Individuals Infected with HIV.
Ucciferri C; Falasca K; Reale M; Tamburro M; Auricchio A; Vignale F; Vecchiet J
Curr HIV Res; 2021; 19(3):260-268. PubMed ID: 33430735
[TBL] [Abstract][Full Text] [Related]
6. Modulation of airway epithelial cell functions by Pidotimod: NF-kB cytoplasmatic expression and its nuclear translocation are associated with an increased TLR-2 expression.
Carta S; Silvestri M; Rossi GA
Ital J Pediatr; 2013 May; 39():29. PubMed ID: 23663325
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulating activity of Pidotimod in children with Down syndrome.
Zuccotti GV; Mameli C; Trabattoni D; Beretta S; Biasin M; Guazzarotti L; Clerici M
J Biol Regul Homeost Agents; 2013; 27(1):253-8. PubMed ID: 23489705
[TBL] [Abstract][Full Text] [Related]
8. Experimental immunological screening tests on pidotimod.
Coppi G; Manzardo S
Arzneimittelforschung; 1994 Dec; 44(12A):1411-6. PubMed ID: 7857333
[TBL] [Abstract][Full Text] [Related]
9. Effects of pidotimod on the immune and the neuroendocrine system in the aging rat.
Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Scapagnini G; Bernardini R
Arzneimittelforschung; 1994 Dec; 44(12A):1437-40. PubMed ID: 7857338
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of pidotimod against experimental bacterial infections in mice.
Coppi G; Falcone A; Manzardo S
Arzneimittelforschung; 1994 Dec; 44(12A):1417-21. PubMed ID: 7857334
[TBL] [Abstract][Full Text] [Related]
11. Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.
Giagulli C; Noerder M; Avolio M; Becker PD; Fiorentini S; Guzman CA; Caruso A
Int Immunopharmacol; 2009 Nov; 9(12):1366-73. PubMed ID: 19712757
[TBL] [Abstract][Full Text] [Related]
12. Synergistic immunostimulatory effect of pidotimod and red ginseng acidic polysaccharide on humoral immunity of immunosuppressed mice.
Du Xiao F; Jiang CZ; Wu CF; Won EK; Choung SY
Pharmazie; 2008 Dec; 63(12):904-8. PubMed ID: 19177908
[TBL] [Abstract][Full Text] [Related]
13. Gene expression for interleukin-2 and tumor necrosis factor-alpha in the spleen of old rats under physiological condition and during septic shock. Possible pharmacological modulation.
Annoni G; Arosio B; Santambrogio D; Cullurà D; Gagliano N; Uslenghi C
Arzneimittelforschung; 1994 Dec; 44(12A):1433-6. PubMed ID: 7531977
[TBL] [Abstract][Full Text] [Related]
14. Pidotimod in the management of vulvar papillomatosis: double-blind clinical trial versus placebo.
Guerra B; Perino A; Polatti F; Scala M
Am J Ther; 1998 May; 5(3):147-52. PubMed ID: 10099052
[TBL] [Abstract][Full Text] [Related]
15. Pidotimod enhanced the anti-growth effect of cisplatin on lung cancer in mice via promoting anti-tumor immune response.
Wu T; Cui J; Gao J; Zhou H; Li A; Guo W
Biochem Biophys Res Commun; 2020 Aug; 528(4):678-684. PubMed ID: 32513535
[TBL] [Abstract][Full Text] [Related]
16. Pidotimod exacerbates allergic pulmonary infection in an OVA mouse model of asthma.
Fu LQ; Li YL; Fu AK; Wu YP; Wang YY; Hu SL; Li WF
Mol Med Rep; 2017 Oct; 16(4):4151-4158. PubMed ID: 28731127
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy of pidotimod in the exacerbations in patients affected with chronic bronchitis.
Bisetti A; Ciappi G; Bariffi F; Catena E; Rocco V; Vaccaro L; Grassi V; Scarpazza G; Bertoli L; Cardani A
Arzneimittelforschung; 1994 Dec; 44(12A):1499-502. PubMed ID: 7857351
[TBL] [Abstract][Full Text] [Related]
18. Pidotimod: a reappraisal.
Riboldi P; Gerosa M; Meroni PL
Int J Immunopathol Pharmacol; 2009; 22(2):255-62. PubMed ID: 19505378
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Pidotimod use in treating allergic rhinitis in a pediatric population.
Brindisi G; Zicari AM; Schiavi L; Gori A; Conte MP; Marazzato M; De Castro G; Leonardi L; Duse M
Ital J Pediatr; 2020 Jul; 46(1):93. PubMed ID: 32635938
[TBL] [Abstract][Full Text] [Related]
20. In vivo antiviral effects of pidotimod.
Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I
Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
